These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 30643975)

  • 1. Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.
    Geibl FF; Henrich MT; Oertel WH
    J Neural Transm (Vienna); 2019 Apr; 126(4):377-396. PubMed ID: 30643975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Threshold Theory for Parkinson's Disease.
    Engelender S; Isacson O
    Trends Neurosci; 2017 Jan; 40(1):4-14. PubMed ID: 27894611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease.
    Vogt Weisenhorn DM; Giesert F; Wurst W
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):8-26. PubMed ID: 27206718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease.
    Billings JL; Gordon SL; Rawling T; Doble PA; Bush AI; Adlard PA; Finkelstein DI; Hare DJ
    J Neurochem; 2019 Jul; 150(1):88-106. PubMed ID: 30716176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.
    Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice.
    Szego ÉM; Gerhardt E; Kermer P; Schulz JB
    Neurobiol Dis; 2012 Jan; 45(1):591-600. PubMed ID: 22001606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
    Herrera A; Muñoz P; Steinbusch HWM; Segura-Aguilar J
    ACS Chem Neurosci; 2017 Apr; 8(4):702-711. PubMed ID: 28233992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease.
    Ikeda-Matsuo Y; Miyata H; Mizoguchi T; Ohama E; Naito Y; Uematsu S; Akira S; Sasaki Y; Tanabe M
    Neurobiol Dis; 2019 Apr; 124():81-92. PubMed ID: 30423474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic dysfunction in Parkinson's disease.
    Picconi B; Piccoli G; Calabresi P
    Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease.
    O'Keeffe GW; Sullivan AM
    Parkinsonism Relat Disord; 2018 Nov; 56():9-15. PubMed ID: 29934196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G
    Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry.
    De Deurwaerdère P; Di Giovanni G; Millan MJ
    Prog Neurobiol; 2017 Apr; 151():57-100. PubMed ID: 27389773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.
    Shen Y; Guo X; Han C; Wan F; Ma K; Guo S; Wang L; Xia Y; Liu L; Lin Z; Huang J; Xiong N; Wang T
    Cell Mol Life Sci; 2017 Oct; 74(20):3741-3768. PubMed ID: 28623510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural ablation of the PARK10 candidate Plpp3 leads to dopaminergic transmission deficits without neurodegeneration.
    Gómez-López S; Martínez-Silva AV; Montiel T; Osorio-Gómez D; Bermúdez-Rattoni F; Massieu L; Escalante-Alcalde D
    Sci Rep; 2016 Apr; 6():24028. PubMed ID: 27063549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing neurogenesis for the possible treatment of Parkinson's disease.
    Lamm O; Ganz J; Melamed E; Offen D
    J Comp Neurol; 2014 Aug; 522(12):2817-30. PubMed ID: 24723264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease as a multisystem disorder.
    Klingelhoefer L; Reichmann H
    J Neural Transm (Vienna); 2017 Jun; 124(6):709-713. PubMed ID: 28155133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of dopaminergic presynaptic function by [F-18] DOPA PET].
    Kato T
    Rinsho Shinkeigaku; 2007 Nov; 47(11):829-31. PubMed ID: 18210809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.